Author of the publication

MSG) Consensus Group

B. Pauw, T. Walsh, J. Donnelly, D. Stevens, J. Edwards, T. Calandra, P. Pappas, J. Maertens, O. Lortholary, C. Kauffman, D. Denning, T. Patterson, G. Maschmeyer, J. Bille, W. Dismukes, R. Herbrecht, W. Hope, C. Kibbler, B. Kullberg, K. Marr, P. Muñoz, F. Odds, J. Perfect, A. Restrepo, M. Ruhnke, B. Segal, J. Sobel, T. Sorrell, C. Viscoli, J. Wingard, T. Zaoutis, and J. Bennett. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 46 (12): 1813--1821 (June 2008)PMID: 18462102.
DOI: 10.1086/588660

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Ralf Maertens

Sabine Maertens

Willi Maertens

Barbara Maertens

Eberhard Maertens

Other publications of authors with the same name

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupB. Pauw, T. Walsh, J. Donnelly, D. Stevens, J. Edwards, T. Calandra, P. Pappas, J. Maertens, O. Lortholary, C. Kauffman and 22 other author(s). Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 46 (12): 1813--1821 (June 2008)PMID: 18462102.Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).O. Cornely, J. Maertens, M. Bresnik, R. Ebrahimi, A. Ullmann, E. Bouza, C. Heussel, O. Lortholary, C. Rieger, A. Boehme and 10 other author(s). Clin Infect Dis, 44 (10): 1289--1297 (May 2007)Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.J. Maertens, A. Glasmacher, R. Herbrecht, A. Thiebaut, C. Cordonnier, B. Segal, J. Killar, A. Taylor, N. Kartsonis, T. Patterson and 4 other author(s). Cancer, 107 (12): 2888--2897 (December 2006)Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.R. Betts, A. Glasmacher, J. Maertens, G. Maschmeyer, J. Vazquez, H. Teppler, A. Taylor, R. Lupinacci, C. Sable, and N. Kartsonis. Cancer, 106 (2): 466--473 (January 2006)Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.F. Marty, P. Ljungman, G. Papanicolaou, D. Winston, R. Chemaly, L. Strasfeld, J. Young, T. Rodriguez, J. Maertens, M. Schmitt and 7 other author(s). Lancet Infect Dis, 11 (4): 284--292 (April 2011)

BibSonomy

Disambiguation of "Maertens, Johan"